Outlook Therapeutics Inc — 재무제표 (NASDAQ:OTLK) | MetaTrader

전체 차트 열기

Financials

개요 성명 통계

총자산 19.73 M22.81 M28.53 M32.3 M28.82 M18.58 M 총 부채 16.91 M18.2 M19.79 M46.74 M101.9 M50.77 M 자본금 총액 2.83 M4.61 M8.74 M-14.44 M-73.08 M-32.19 M 총 부채 및 주주자본 19.73 M22.81 M28.53 M32.3 M28.82 M18.58 M 총부채 984.26 K11.82 M———— 순부채 -11.55 M-2.66 M————

뉴스

Outlook Therapeutics Files FDA Resolution Request After Rejection For Vision Loss Drug - Outlook Therapeu

아웃룩 테라퓨틱스, 1840만 달러 규모의 채권 확보 및 만기 연장

Outlook Therapeutics secures $18.4M note, extends debt maturity

아웃룩 테라퓨틱스, 베바시주맙 약물 관련 FDA 회의 논의

Outlook Therapeutics discusses FDA meeting on bevacizumab drug

Oncobiologics, Inc. (OTLK) Reports Q1 Loss, Misses Revenue Estimates

OTLK Stock Crashes 67% in a Week: Here's What You Need to Know

Outlook Therapeutics, 기업 전략 부사장으로 Laura Cantrell 임명

아웃룩 테라퓨틱스(OTLK) 목표 주가, H.C. Wainwright, 0.5달러로 하향

Outlook Therapeutics stock price target lowered to $0.50 at H.C. Wainwright

Dow Jumps Over 300 Points On First Trading Day Of 2026: Fear & Greed Index Remains In 'Neutral Zone - Micron Technology (NASDAQ:MU), NVIDIA (NASDAQ:NVDA)

The Narrowing Pathway for Biotech Securities Fraud Claims: Lessons from Outlook Therapeutics - TipRanks.com